470 related articles for article (PubMed ID: 11697683)
1. Treatment options for depression and psychosis in Parkinson's disease.
Poewe W; Seppi K
J Neurol; 2001 Sep; 248 Suppl 3():III12-21. PubMed ID: 11697683
[TBL] [Abstract][Full Text] [Related]
2. Treatment of behavioural symptoms and dementia in Parkinson's disease.
Hanagasi HA; Emre M
Fundam Clin Pharmacol; 2005 Apr; 19(2):133-46. PubMed ID: 15810893
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology and treatment of psychosis in Parkinson's disease: a review.
Zahodne LB; Fernandez HH
Drugs Aging; 2008; 25(8):665-82. PubMed ID: 18665659
[TBL] [Abstract][Full Text] [Related]
4. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
5. Treatment of psychosis in Parkinson's disease: safety considerations.
Fernandez HH; Trieschmann ME; Friedman JH
Drug Saf; 2003; 26(9):643-59. PubMed ID: 12814332
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
Meco G; Bernardi S
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
[TBL] [Abstract][Full Text] [Related]
7. Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease.
Broadstock M; Ballard C; Corbett A
Expert Rev Clin Pharmacol; 2014 Nov; 7(6):779-86. PubMed ID: 25301532
[TBL] [Abstract][Full Text] [Related]
8. Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis.
Frieling H; Hillemacher T; Ziegenbein M; Neundörfer B; Bleich S
Eur Neuropsychopharmacol; 2007 Feb; 17(3):165-71. PubMed ID: 17070675
[TBL] [Abstract][Full Text] [Related]
9. Psychiatric syndromes in Parkinson's disease.
Starkstein SE; Brockman S; Hayhow BD
Curr Opin Psychiatry; 2012 Nov; 25(6):468-72. PubMed ID: 22992542
[TBL] [Abstract][Full Text] [Related]
10. Clozapine in Parkinson's disease psychosis: 5-year follow-up review.
Klein C; Gordon J; Pollak L; Rabey JM
Clin Neuropharmacol; 2003; 26(1):8-11. PubMed ID: 12567158
[TBL] [Abstract][Full Text] [Related]
11. Psychiatric aspects of Parkinson's disease--an update.
Schrag A
J Neurol; 2004 Jul; 251(7):795-804. PubMed ID: 15258780
[TBL] [Abstract][Full Text] [Related]
12. [Clozapine and olanzapine in the treatment of the psychotic disorders in Parkinson's disease].
Chacón J
Rev Neurol; 2004 Oct 1-15; 39(7):655-60. PubMed ID: 15490354
[TBL] [Abstract][Full Text] [Related]
13. [Psychosis in Parkinson's disease].
Rongve A; Auning E; Ehrt U; Arsland D
Tidsskr Nor Laegeforen; 2012 Jan; 132(2):155-8. PubMed ID: 22278271
[TBL] [Abstract][Full Text] [Related]
14. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
Wilby KJ; Johnson EG; Johnson HE; Ensom MHH
Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039
[TBL] [Abstract][Full Text] [Related]
15. Current Understanding of Psychosis in Parkinson's Disease.
Ojo OO; Fernandez HH
Curr Psychiatry Rep; 2016 Oct; 18(10):97. PubMed ID: 27629356
[TBL] [Abstract][Full Text] [Related]
16. The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's Disease.
Divac N; Stojanović R; Savić Vujović K; Medić B; Damjanović A; Prostran M
Behav Neurol; 2016; 2016():4938154. PubMed ID: 27504054
[TBL] [Abstract][Full Text] [Related]
17. Atypical antipsychotic drugs in the treatment of Parkinson's disease.
Friedman JH
J Pharm Pract; 2011 Dec; 24(6):534-40. PubMed ID: 22095576
[TBL] [Abstract][Full Text] [Related]
18. Drug Choices and Advancements for Managing Depression in Parkinson's Disease.
Assogna F; Pellicano C; Savini C; Macchiusi L; Pellicano GR; Alborghetti M; Caltagirone C; Spalletta G; Pontieri FE
Curr Neuropharmacol; 2020; 18(4):277-287. PubMed ID: 31622207
[TBL] [Abstract][Full Text] [Related]
19. An update expert opinion on management and research strategies in Parkinson's disease psychosis.
Goldman JG; Vaughan CL; Goetz CG
Expert Opin Pharmacother; 2011 Sep; 12(13):2009-24. PubMed ID: 21635198
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological interventions for psychosis in Parkinson's disease patients.
Friedman JH
Expert Opin Pharmacother; 2018 Apr; 19(5):499-505. PubMed ID: 29494265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
